Status
Conditions
Treatments
About
This is a multicenter randomised controlled trial to assess whether standardised enteral feeding in newborns with duct dependenty congenital heart disease decreases the risk of necrotising enterocolitis (NEC). The investigators plan to include a total 384 infants. The study will be carried out in three level III hospitals in Poland. The primary end will be NEC and/or death. Secondary end points include weight gain, hospital length of stay, time required to reach full feeding.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
384 participants in 2 patient groups
Loading...
Central trial contact
Renata Bokiniec, MD PhD; Ariel Płotko, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal